Menu
Back to Journals » Pharmacogenomics and Personalized Medicine » Volume 16 » default
Pharmacogenomics and Personalized Medicine
ISSN: 1178-7066
- View all (634)
- Volume 17, 2024 (13)
- Volume 16, 2023 (97)
- Volume 15, 2022 (82)
- Volume 14, 2021 (155)
- Volume 13, 2020 (72)
- Volume 12, 2019 (34)
- Volume 11, 2018 (24)
- Volume 10, 2017 (31)
- Volume 9, 2016 (14)
- Volume 8, 2015 (16)
- Volume 7, 2014 (37)
- Volume 6, 2013 (15)
- Volume 5, 2012 (12)
- Volume 4, 2011 (10)
- Volume 3, 2010 (11)
- Volume 2, 2009 (9)
- Volume 1, 2008 (2)
Archive: Volume 16, 2023
Identification of Novel Prognostic Biomarkers That are Associated with Immune Microenvironment Based on GABA-Related Molecular Subtypes in Gastric Cancer [Corrigendum]
Wang B, Huang L, Ye S, Zheng Z, Liao S
Pharmacogenomics and Personalized Medicine 2023, 16:1149-1150
Published Date: 29 December 2023
Challenges in DPYD Test Implementation in Patients Treated with Fluoropyrimidines are DPYD Genotype Arriving on Time? [Letter]
López López-Cepero M, Obrador de Hevia A, Guillot Morales M
Pharmacogenomics and Personalized Medicine 2023, 16:1145-1147
Published Date: 28 December 2023
Heme Metabolism-Related Gene TENT5C is a Prognostic Marker and Investigating Its Immunological Role in Colon Cancer
Han W, Li C, Wang Y, Huo B, Li W, Shi W
Pharmacogenomics and Personalized Medicine 2023, 16:1127-1143
Published Date: 23 December 2023
BICDL1 Predicts Poor Prognosis and is Correlated with Methylation and Immune Infiltration in Colorectal Cancer
Luo H, Luo J, Ding N, Zhang T, He Y
Pharmacogenomics and Personalized Medicine 2023, 16:1109-1126
Published Date: 22 December 2023
Olanzapine Pharmacokinetics: A Clinical Review of Current Insights and Remaining Questions
Kolli P, Kelley G, Rosales M, Faden J, Serdenes R
Pharmacogenomics and Personalized Medicine 2023, 16:1097-1108
Published Date: 21 December 2023
A Case of Floating-Harbor Syndrome with “Growth and Language Development Delay” as Its Clinical Manifestation
Yang YC, Tang Q, Yan LJ, Zhang SB, Ye XM, Gong D, Zou L, Wen XL
Pharmacogenomics and Personalized Medicine 2023, 16:1091-1096
Published Date: 15 December 2023
Circ_0000140 Alters miR-527/SLC7A11-Mediated Ferroptosis to Influence Oral Squamous Cell Carcinoma Cell Resistance to DDP
Ma Y, Gao J, Guo H
Pharmacogenomics and Personalized Medicine 2023, 16:1079-1089
Published Date: 13 December 2023
A Review on Probable Causes of Cardiotoxicity Caused by Common Cancer Drugs and the Role of Traditional Chinese Medicine in Prevention and Treatment
Zhou M, Wang W, Weng J, Lai Z
Pharmacogenomics and Personalized Medicine 2023, 16:1067-1077
Published Date: 6 December 2023
Novel Autophagy-Related Blood Biomarkers Associated with Immune Cell Infiltration in Ankylosing Spondylitis
Song H, Liu H, Li X, Lv B, Tang Z, Chen Q, Zhang D, Wang F
Pharmacogenomics and Personalized Medicine 2023, 16:1055-1066
Published Date: 5 December 2023
Identification of P3H1 as a Predictive Prognostic Biomarker for Bladder Urothelial Carcinoma Based on the Cancer Genome Atlas Database
Zhang Y, Chen Y, Chen Z, Zhou X, Chen S, Lan K, Wang Z, Zhang Y
Pharmacogenomics and Personalized Medicine 2023, 16:1041-1053
Published Date: 1 December 2023
Implication of KDR Polymorphism rs2071559 on Therapeutic Outcomes and Safety of Postoperative Patients with Gastric Cancer Who Received S-1-Based Adjuvant Chemotherapy: A Real-World Exploratory Study
Meng L, Cao J, Kang L, Xu G, Yuan DW, Li K, Zhu K
Pharmacogenomics and Personalized Medicine 2023, 16:1027-1039
Published Date: 28 November 2023
Clinical Characteristics and Prognosis of Acute Myeloid Leukemia Patients with Protein Tyrosine Phosphatase Non-Receptor Type 11 Gene Mutation
Huang R, Zhang YT, Lin Y, Pang RL, Yang Z, Zhao WH
Pharmacogenomics and Personalized Medicine 2023, 16:1011-1026
Published Date: 11 November 2023
PLP2 Could Be a Prognostic Biomarker and Potential Treatment Target in Glioblastoma Multiforme
Qiao H, Li H
Pharmacogenomics and Personalized Medicine 2023, 16:991-1009
Published Date: 9 November 2023
Personalized Approaches to Antiplatelet Treatment for Cardiovascular Diseases: An Umbrella Review
Oliva A, Cao D, Spirito A, Nicolas J, Pileggi B, Kamaleldin K, Vogel B, Mehran R
Pharmacogenomics and Personalized Medicine 2023, 16:973-990
Published Date: 3 November 2023
Identification of a Prognostic Gene Signature Based on Lipid Metabolism-Related Genes in Esophageal Squamous Cell Carcinoma
Shen GY, Yang PJ, Zhang WS, Chen JB, Tian QY, Zhang Y, Han B
Pharmacogenomics and Personalized Medicine 2023, 16:959-972
Published Date: 4 November 2023
Hepatic Artery Infusion Chemotherapy Sequential Hepatic Artery Embolization Combined with Operation in the Treatment of Recurrent Massive Hepatocellular Carcinoma Achieved Pathological Complete Response: A Case Report
Chen J, Liao X, Wu Y, Ou S, Qin W, Yang C, Tan Y, Lao Q, Peng M, Peng T, Ye X
Pharmacogenomics and Personalized Medicine 2023, 16:949-958
Published Date: 1 November 2023
rs217727 of lncRNA H19 is Associated with Cervical Cancer Risk in the Chinese Han Population
Dai J, Zhang S, Shi Y, Xu J, Liu W, Yang J, Shi L, Yan Z, Li C
Pharmacogenomics and Personalized Medicine 2023, 16:933-948
Published Date: 30 October 2023
Association Between CTSK Gene Polymorphisms and Response to Alendronate Treatment in Postmenopausal Chinese Women with Low Bone Mineral Density
Yuan H, Wang C, Liu L, Wang C, Zhang Z, Qu S
Pharmacogenomics and Personalized Medicine 2023, 16:925-932
Published Date: 28 October 2023
Microarray Expression Profile and Bioinformatic Analysis of Circular RNA in Human Arteriosclerosis Obliterans
Zhou Y, Cai H, Huang L, Wang M, Liu R, Wang S, Qin Y, Yao C, Hu Z
Pharmacogenomics and Personalized Medicine 2023, 16:913-924
Published Date: 24 October 2023
A Case Report of Cardiofaciocutaneous Syndrome with MAP2K1 Pathogenic Variant [Letter]
Furqoni AH, Fajarwati I, Poetranto AL
Pharmacogenomics and Personalized Medicine 2023, 16:911-912
Published Date: 25 October 2023
Influence of CYP450 Enzymes and ABCB1 Polymorphisms on Clopidogrel Response in Moroccan Patients with Acute Coronary Syndromes
Mouhrach I, Bouguenouch L, Kamal A, Meriame A, El Khorb N, El Azami El Idrissi M, Akoudad H, Bekkari H
Pharmacogenomics and Personalized Medicine 2023, 16:901-909
Published Date: 2 October 2023
Homocysteine Reduction for Stroke Prevention: Regarding the Recent AHA/ASA 2021 Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
Brown C, Wang J, Jiang H, Elias MF
Pharmacogenomics and Personalized Medicine 2023, 16:895-900
Published Date: 3 October 2023
Novel MYBPC3 Mutations in Indian Population with Cardiomyopathies
Rani DS, Kasala A, Dhandapany PS, Muthusami U, Kunnoth S, Rathinavel A, Ayapati DR, Thangaraj K
Pharmacogenomics and Personalized Medicine 2023, 16:883-893
Published Date: 20 September 2023
Genome-Wide Identification of lncRNA and mRNA for Diagnosing Type 2 Diabetes in Saudi Arabia
Albogami S
Pharmacogenomics and Personalized Medicine 2023, 16:859-882
Published Date: 15 September 2023
Clinical Significance of NAT2 Genetic Variations in Type II Diabetes Mellitus and Lipid Regulation
Jarrar Y, Abudahab S, Abdul-Wahab G, Zaiter D, Madani A, Abaalkhail SJ, Abulebdah D, Alhawari H, Musleh R, Lee SJ
Pharmacogenomics and Personalized Medicine 2023, 16:847-857
Published Date: 13 September 2023
Chromosomal Copy Number Variation Predicts EGFR-TKI Response and Prognosis for Patients with Non-Small Cell Lung Cancer
He H, Ma H, Chen Z, Chen J, Wu D, Lv X, Zhu J
Pharmacogenomics and Personalized Medicine 2023, 16:835-846
Published Date: 13 September 2023
Genetic Polymorphism of NQO1 Influences Susceptibility to Coronary Heart Disease in a Chinese Population: A Cross-Sectional Study and Meta-Anaylsis
Zhou YY, Sun JH, Wang L, Cheng YY
Pharmacogenomics and Personalized Medicine 2023, 16:825-833
Published Date: 11 September 2023
A Case Report of Cardiofaciocutaneous Syndrome with MAP2K1 Pathogenic Variant
Tang Q, Gong D, Ye XM, Xu JR, Yang YC, Yan LJ, Zou L, Wen XL
Pharmacogenomics and Personalized Medicine 2023, 16:817-823
Published Date: 8 September 2023
Hsa_circ_0003489 Drives PTX Resistance of Human NSCLC Cells Through Modulating miR-98-5p/IGF2
Xia S, Wang C
Pharmacogenomics and Personalized Medicine 2023, 16:805-815
Published Date: 4 September 2023
Pyroptosis and Inflammasome-Related Genes-NLRP3, NLRC4 and NLRP7 Polymorphisms Were Associated with Risk of Lung Cancer
Jing X, Yun Y, Ji X, Yang E, Li P
Pharmacogenomics and Personalized Medicine 2023, 16:795-804
Published Date: 25 August 2023
A Case-Control Study of the Relationship Between Genetic Polymorphism and Cretinism in Xinjiang
Huang J, Wu H, Zhao G, Ma Y, An Y, Sun L, Li F, Wang S
Pharmacogenomics and Personalized Medicine 2023, 16:785-794
Published Date: 23 August 2023
Clinical Characteristics and Novel ZEB2 Gene Mutation Analysis of Three Chinese Patients with Mowat-Wilson Syndrome
Han X, Zhang Q, Wang C, Han B
Pharmacogenomics and Personalized Medicine 2023, 16:777-783
Published Date: 23 August 2023
A Case Study and Literature Review of the Diagnosis of Danon Disease in Patients Presenting Only with Severe Cardiac Symptoms
Sun YQ, Lv Q, Chen D, Da Y, Zhao XY, Dong JZ
Pharmacogenomics and Personalized Medicine 2023, 16:767-775
Published Date: 17 August 2023
Identification of Two Novel Variants of the DMD Gene in Chinese Families with Duchenne Muscular Dystrophy
Wu J, Ren L, Huang X, Hu L, Zhang L, Xie D, Li Z, Han N, Huang S
Pharmacogenomics and Personalized Medicine 2023, 16:759-766
Published Date: 17 August 2023
PSMC2 is a Novel Prognostic Biomarker and Predicts Immunotherapeutic Responses: From Pancreatic Cancer to Pan-Cancer
Huang W, Qian Z, Shi Y, Zhang Z, Hou R, Mei J, Xu J, Ding J
Pharmacogenomics and Personalized Medicine 2023, 16:747-758
Published Date: 9 August 2023
Pharmacogenetic Practice of Anticancer Drugs: Multiple Approaches for an Accurate and Comprehensive Genotyping
Montrasio C, Cheli S, Clementi E
Pharmacogenomics and Personalized Medicine 2023, 16:739-746
Published Date: 27 July 2023
Pharmacogenomics in the Management of Pulmonary Arterial Hypertension: Current Perspectives
Coons JC, Empey PE
Pharmacogenomics and Personalized Medicine 2023, 16:729-737
Published Date: 11 July 2023
Association Between HTRA1, GAS6 and IFNGR2 Gene Polymorphisms and Stroke Susceptibility in the Chinese Han Population
Zhang F, Peng H, Fu C, Deng Y, Zhang M, Li W, Zhong J, Zhou Q, Huang L, Xiao S, Zhao J
Pharmacogenomics and Personalized Medicine 2023, 16:717-727
Published Date: 7 July 2023
Impact of TREM1 Variants on the Risk and Prognosis of Glioma in the Chinese Han Population
Hu M, Wei J, Hao J, Jin T, Li B
Pharmacogenomics and Personalized Medicine 2023, 16:707-715
Published Date: 3 July 2023
Genotyping of Patients with Adverse Drug Reaction or Therapy Failure: Database Analysis of a Pharmacogenetics Case Series Study
Bollinger A, Stäuble CK, Jeiziner C, Wiss FM, Hersberger KE, Lampert ML, Meyer zu Schwabedissen HE, Allemann SS
Pharmacogenomics and Personalized Medicine 2023, 16:693-706
Published Date: 3 July 2023
Are We Ready for Whole Population Genomic Sequencing of Asymptomatic Newborns?
Vears DF, Savulescu J, Christodoulou J, Wall M, Newson AJ
Pharmacogenomics and Personalized Medicine 2023, 16:681-691
Published Date: 1 July 2023
Identification of Novel Prognostic Biomarkers That are Associated with Immune Microenvironment Based on GABA-Related Molecular Subtypes in Gastric Cancer
Wang B, Huang L, Ye S, Zheng Z, Liao S
Pharmacogenomics and Personalized Medicine 2023, 16:665-679
Published Date: 28 June 2023
A Pharmacogenetics-Based Approach to Managing Gastroesophageal Reflux Disease: Current Perspectives and Future Steps
Eken E, Estores DS, Cicali EJ, Wiisanen KK, Johnson JA
Pharmacogenomics and Personalized Medicine 2023, 16:645-664
Published Date: 23 June 2023
Integrated Bioinformatics Analysis and Experimental Verification of Immune Cell Infiltration and the Related Core Genes in Ulcerative Colitis
Zhao D, Qin D, Yin L, Yang Q
Pharmacogenomics and Personalized Medicine 2023, 16:629-643
Published Date: 23 June 2023
The Association of Methylation Level in the CYP39A1 Gene with High Altitude Pulmonary Edema in the Chinese Population
Wang P, Lu H, Rong H, Wang Y, Wang L, He X, Yuan D, He Y, Jin T
Pharmacogenomics and Personalized Medicine 2023, 16:617-628
Published Date: 21 June 2023
One Rare Warfarin Resistance Case and Possible Mechanism Exploration
Zhao L, Zhai Z, Li P
Pharmacogenomics and Personalized Medicine 2023, 16:609-615
Published Date: 20 June 2023
Genetic Variants of CYP4F2 Associated with Ischemic Stroke Susceptibility in the Han Population from Southern China
Huang K, Ma T, Li Q, Zhou Y, Qin T, Zhong Z, Tang S, Zhang W, Zhong J, Lu S
Pharmacogenomics and Personalized Medicine 2023, 16:599-607
Published Date: 15 June 2023
Exploration into Plasma Hsa_circ_0052184 as a New Biomarker of Colorectal Cancer Prognosis
Zheng E, Xiao D
Pharmacogenomics and Personalized Medicine 2023, 16:589-597
Published Date: 12 June 2023
Clinical and Gene Analysis of Fatty Acid Oxidation Disorders Found in Neonatal Tandem Mass Spectrometry Screening
Wang X, Fang H
Pharmacogenomics and Personalized Medicine 2023, 16:577-587
Published Date: 5 June 2023
Genetic Influence of Fracture Nonunion (FNU): A Systematic Review
Sadat-Ali M, Al-Omar HK, AlTabash KW, AlOmran AK, AlDakheel DA, AlSayed HN
Pharmacogenomics and Personalized Medicine 2023, 16:569-575
Published Date: 5 June 2023
Leucyl and Cystinyl Aminopeptidase as a Prognostic-Related Biomarker in OV Correlating with Immune Infiltrates
Ma Q, Chang L, Wang W, Che L, Song X, Li G, Zhang Y, Chen Y, Gu Z, Ge X
Pharmacogenomics and Personalized Medicine 2023, 16:551-568
Published Date: 2 June 2023
Serum Osteopontin, KL-6, and Syndecan-4 as Potential Biomarkers in the Diagnosis of Coal Workers’ Pneumoconiosis: A Case–Control Study
Hou Z, Zhang X, Gao Y, Geng J, Jiang Y, Dai H, Wang C
Pharmacogenomics and Personalized Medicine 2023, 16:537-549
Published Date: 1 June 2023
Exploring the Correlation Between GPR176, a Potential Target Gene of Gastric Cancer, and Immune Cell Infiltration
Gu X, Shen H, Xiang Z, Li X, Zhang Y, Zhang R, Su F, Wang Z
Pharmacogenomics and Personalized Medicine 2023, 16:519-535
Published Date: 1 June 2023
Mental Health Prescribers’ Perceptions on the Use of Pharmacogenetic Testing in the Management of Depression in the Middle East and North Africa Region
Aboelbaha S, Zolezzi M, Abdallah O, Eltorki Y
Pharmacogenomics and Personalized Medicine 2023, 16:503-518
Published Date: 30 May 2023
Role of CYP19A1 Loci (rs28757157 and rs3751591) with Ischemic Stroke Risk in the Chinese Han Population
Huang K, Ma T, Li Q, Zhong Z, Qin T, Zhou Y, Zhang W, Tang S, Zhong J, Lu S
Pharmacogenomics and Personalized Medicine 2023, 16:491-502
Published Date: 29 May 2023
Plasma Homocysteine (Hcy) Concentration Functions as a Predictive Biomarker of SPECT-Evaluated Post-Ischemic Hyperperfusion in Acute Ischemic Stroke
Wang Y, Hou R, Liu Y
Pharmacogenomics and Personalized Medicine 2023, 16:481-489
Published Date: 25 May 2023
Exploration and Validation of Pancreatic Cancer Hub Genes Based on Weighted Gene Co-Expression Network Analysis and Immune Infiltration Score Analysis
Li XX, Li H, Jin LQ, Tan YB
Pharmacogenomics and Personalized Medicine 2023, 16:467-480
Published Date: 22 May 2023
Giant Multilocular-Cystic Metaplastic Thymoma: A Case Report
Han L, Gao B, Wang EH, Wang L
Pharmacogenomics and Personalized Medicine 2023, 16:463-466
Published Date: 19 May 2023
The Influence of Cytochrome P450 Polymorphisms on Pharmacokinetic Profiles and Treatment Outcomes Among Malaria Patients in Sub-Saharan Africa: A Systematic Review
Marwa KJ, Kapesa A, Kamugisha E, Swedberg G
Pharmacogenomics and Personalized Medicine 2023, 16:449-461
Published Date: 18 May 2023
Case Report: A Novel Homozygous Mutation of Cyclin O Gene Mutation in Primary Ciliary Dyskinesia with Short Stature
Gong D, Tang Q, Yan LJ, Ye XM, Yang YC, Zou L, Ji Q, Wen XL
Pharmacogenomics and Personalized Medicine 2023, 16:443-448
Published Date: 17 May 2023
Clinical Knowledge, Attitude, and Perceptions of Community Pharmacists Towards Pharmacogenomics - A Cross-Sectional Study from Saudi Arabia
Alrabiah Z, Syed W, Babelghaith SD, Al Arifi MN
Pharmacogenomics and Personalized Medicine 2023, 16:433-441
Published Date: 8 May 2023
A Preliminary Study on the Correlation Between Age and Endometrial Receptivity
Guo S, Zhang D, Zhao S, Zhang H, Sun Y, Yan L
Pharmacogenomics and Personalized Medicine 2023, 16:425-432
Published Date: 6 May 2023
MTHFR and MTRR Genetic Polymorphism of Methotrexate Therapy Outcomes in Early Rheumatoid Arthritis
Zhang Q, Fu P, Cao Z, Huang H, Wen Q, Wang K, Kong T, Wu X, Zheng J
Pharmacogenomics and Personalized Medicine 2023, 16:407-423
Published Date: 2 May 2023
Acute Myeloid Leukemia Secondary to Chronic Lymphocytic Leukemia After Prolonged Chlorambucil Therapy: A Case Report
Wu Y, Liu S, Wang D, Yao X
Pharmacogenomics and Personalized Medicine 2023, 16:401-405
Published Date: 27 April 2023
NOTCH2, ATIC, MRI1, SLC6A13, ATP13A2 Genetic Variations are Associated with Ventricular Septal Defect in the Chinese Tibetan Population Through Whole-Exome Sequencing
Zhang X, Zhen D, Li X, Yi F, Zhang Z, Yang W, Li X, Sheng Y, Liu X, Jin T, He Y
Pharmacogenomics and Personalized Medicine 2023, 16:389-400
Published Date: 27 April 2023
Expression and Correlation of MIF and ERK1/2 in Liver Cirrhosis and Hepatocellular Carcinoma Induced by Hepatitis B
Jia D, Li B, Wang JK, Wang P, Li CY, Lu LX, Tian WY, Yu XH, Zhang JC, Zheng Y
Pharmacogenomics and Personalized Medicine 2023, 16:381-388
Published Date: 24 April 2023
Case Report: Congenital Myasthenic Syndrome Presenting with Bilateral Vocal Cord Paralysis Caused by De-Novel Compound Heterozygous MUSK Mutation
Jiang L, Wang SC, Zhang J, Han FG, Zhao J, Xu Y
Pharmacogenomics and Personalized Medicine 2023, 16:373-379
Published Date: 17 April 2023
GABRP is a Promising Prognostic Biomarker and Associated with Immune Cell Infiltration in Lung Squamous Cell Carcinoma
Fu J, Lin J, Zeng X, Li G, Wei Y, Xian L
Pharmacogenomics and Personalized Medicine 2023, 16:357-371
Published Date: 15 April 2023
PUS1 May Be a Potential Prognostic Biomarker and Therapeutic Target for Hepatocellular Carcinoma
Lan C, Huang X, Liao X, Zhou X, Peng K, Wei Y, Han C, Peng T, Wang J, Zhu G
Pharmacogenomics and Personalized Medicine 2023, 16:337-355
Published Date: 15 April 2023
Transporter Associated with Antigen Processing 1 Gene Polymorphisms Increase the Susceptibility to Tuberculosis
Lu T, Wang M, Liu N, Zhang S, Shi L, Bao L, Luo F, Shi L, Liu S, Yao Y
Pharmacogenomics and Personalized Medicine 2023, 16:325-336
Published Date: 13 April 2023
miR-139-5p and miR-451a as a Diagnostic Biomarker in LUSC
Gao B, Li R, Song X, Hu S, Yang F
Pharmacogenomics and Personalized Medicine 2023, 16:313-323
Published Date: 8 April 2023
Apolipoprotein E Gene Polymorphism Effects on Lipid Metabolism and Risk of Cerebral Infarction in Northwest Han Chinese Population
Wang Y, Yang S, Zhang S, Lu X, Ma W
Pharmacogenomics and Personalized Medicine 2023, 16:303-312
Published Date: 5 April 2023
Construction and Validation of a Novel Nomogram for Predicting the Recurrence of Diffuse Large B Cell Lymphoma Treated with R-CHOP
Gong Y, Yan H, Yang Y, Zhai B, Huang Z, Zhang Z
Pharmacogenomics and Personalized Medicine 2023, 16:291-301
Published Date: 1 April 2023
Rs11479 in Thymidine Phosphorylase Associated with Prognosis of Patients with Colorectal Cancer Who Received Capecitabine-Based Adjuvant Chemotherapy
Jia X, Zhang T, Sun J, Lin H, Bai T, Qiao Y, Li Y, Li G, Li G, Peng X, Zhang A
Pharmacogenomics and Personalized Medicine 2023, 16:277-289
Published Date: 31 March 2023
Use of Continuous Glucose Monitors to Manage Type 1 Diabetes Mellitus: Progress, Challenges, and Recommendations
Friedman JG, Cardona Matos Z, Szmuilowicz ED, Aleppo G
Pharmacogenomics and Personalized Medicine 2023, 16:263-276
Published Date: 31 March 2023
RUNX2 Reverses p53-Induced Chemotherapy Resistance in Gastric Cancer
Huang Y, Liang L, Zhao YX, Yao BH, Zhang RM, Song L, Zhang ZT
Pharmacogenomics and Personalized Medicine 2023, 16:253-261
Published Date: 27 March 2023
Current Understanding of Inherited Modifiers of FVIII Pharmacokinetic Variation
Swystun LL, Lillicrap D
Pharmacogenomics and Personalized Medicine 2023, 16:239-252
Published Date: 24 March 2023
The Allelic Expression of RNA Editing Gene ADARB1 in Hepatocellular Carcinoma Treated with Transarterial Chemoembolization
Zeng J, Han L, Wang T, Huang L, Zheng Y, Zhang N, Li Z, Yang M
Pharmacogenomics and Personalized Medicine 2023, 16:229-238
Published Date: 18 March 2023
Anlotinib Enhances the Therapeutic Effect of Bladder Cancer with GSDMB Expression: Analyzed from TCGA Bladder Cancer Database & Mouse Bladder Cancer Cell Line
Wang C, Cao Q, Zhang S, Liu H, Duan H, Xia W, Shen H, Wang C
Pharmacogenomics and Personalized Medicine 2023, 16:219-228
Published Date: 17 March 2023
Discovery of Drug-Responsive Phenomic Alteration-Related Driver Genes in the Treatment of Coronary Heart Disease
Guan S, Yu YN, Li B, Gu H, Chen L, Wang N, Wang B, Liu X, Liu J, Wang Z
Pharmacogenomics and Personalized Medicine 2023, 16:201-217
Published Date: 15 March 2023
Resistance to PARP Inhibitors After First-Line Platinum-Based Chemotherapy in a Patient with Advanced Ovarian Cancer with a Pathogenic Somatic BRCA1 Mutation
Zhong L, Yin R, Song L
Pharmacogenomics and Personalized Medicine 2023, 16:195-200
Published Date: 14 March 2023
Dysregulation of circRNA-0076906 and circRNA-0134944 is Correlated with Susceptibility to Osteoporosis and Osteoporotic Fracture in Postmenopausal Females from the Chinese Han Population
Yang W, Zhang W, Li F, Xu N, Sun P
Pharmacogenomics and Personalized Medicine 2023, 16:183-194
Published Date: 10 March 2023
Detection of Novel Pathogenic Variants in Two Families with Recurrent Fetal Congenital Heart Defects
Cai R, Tan Y, Wang M, Yu H, Wang J, Ren Z, Dong Z, He Y, Li Z, Lin L, Gu Y
Pharmacogenomics and Personalized Medicine 2023, 16:173-181
Published Date: 8 March 2023
Nidogen-2 (NID2) is a Key Factor in Collagen Causing Poor Response to Immunotherapy in Melanoma
Sha Y, Mao AQ, Liu YJ, Li JP, Gong YT, Xiao D, Huang J, Gao YW, Wu MY, Shen H
Pharmacogenomics and Personalized Medicine 2023, 16:153-172
Published Date: 4 March 2023
Hydroxychloroquine Ameliorates Hematuria in Children with X-Linked Alport Syndrome: Retrospective Case Series Study
Sun L, Kuang XY, Zhang J, Huang WY
Pharmacogenomics and Personalized Medicine 2023, 16:145-151
Published Date: 25 February 2023
Genotypic and Phenotypic Composition of Sickle Cell Disease in the Arab Population - A Systematic Review
Ata F, Rahhal A, Malkawi L, Iqbal P, Khamees I, Alhiyari M, Yousaf Z, Qasim H, Alshurafa A, Sardar S, Javed S, Fernyhough L, Yassin M
Pharmacogenomics and Personalized Medicine 2023, 16:133-144
Published Date: 21 February 2023
Clinical Associations of Bitter Taste Perception and Bitter Taste Receptor Variants and the Potential for Personalized Healthcare
Mao Z, Cheng W, Li Z, Yao M, Sun K
Pharmacogenomics and Personalized Medicine 2023, 16:121-132
Published Date: 12 February 2023
Massive Hepatocellular Carcinoma with Situs Inversus Totalis Achieved a Complete Response Following Camrelizumab Plus Apatinib and Combined with Two-Stage Hepatectomy: A Case Report
Wu Y, Ou S, Liao X, Han C, Yang C, Qin W, Tan Y, Lao Q, Peng T, Ye X
Pharmacogenomics and Personalized Medicine 2023, 16:111-120
Published Date: 7 February 2023
LncRNA FOXD2-AS1 Increased Proliferation and Invasion of Lung Adenocarcinoma via Cell-Cycle Regulation
Yuan Y, Yu P, Shen H, Xing G, Li W
Pharmacogenomics and Personalized Medicine 2023, 16:99-109
Published Date: 3 February 2023
A Retrospective Analysis of Clinically Focused Exome Sequencing Results of 372 Infants with Suspected Monogenic Disorders in China
Jia A, Lei Y, Liu DP, Pan L, Guan HZ, Yang B
Pharmacogenomics and Personalized Medicine 2023, 16:81-97
Published Date: 2 February 2023
Screening of Lymphoma Radiotherapy-Resistant Genes with CRISPR Activation Library
Luo BH, Huang JQ, Huang CY, Tian P, Chen AZ, Wu WH, Ma XM, Yuan YX, Yu L
Pharmacogenomics and Personalized Medicine 2023, 16:67-80
Published Date: 30 January 2023
The Relationship Between MMP17 Variants and Ischemic Stroke Risk in the Population from Shaanxi Province in China
Li W, Liu Y, Xu X, Zhang Q, Zhang X, Zhang J, Niu X, Yang S, Zhang X, Shi W, Zhang G, Chang M, Tian Y
Pharmacogenomics and Personalized Medicine 2023, 16:59-66
Published Date: 30 January 2023
Identification and Validation of Ferroptosis-Related Subtypes and a Predictive Signature in Hepatocellular Carcinoma
Zheng C, Peng Y, Wang H, Wang Y, Liu L, Zhao Q
Pharmacogenomics and Personalized Medicine 2023, 16:39-58
Published Date: 26 January 2023
DNA Methylation Level of Transcription Factor Binding Site in the Promoter Region of Acyl-CoA Synthetase Family Member 3 (ACSF3) in Saudi Autistic Children [Corrigendum]
Algothmi K, Alqurashi A, Alrofaidi A, Alharbi M, Farsi R, Alburae N, Ganash M, Azhari S, Basingab F, Almuhammadi A, Alqosaibi A, Alkhatabi H, Elaimi A, Jan M, Aldhalaan H, Alrafiah A, Alhazmi S
Pharmacogenomics and Personalized Medicine 2023, 16:37-38
Published Date: 25 January 2023
A Review of the Pharmacokinetic Characteristics of Immune Checkpoint Inhibitors and Their Clinical Impact Factors
Liu JC, Yu HJ
Pharmacogenomics and Personalized Medicine 2023, 16:29-36
Published Date: 20 January 2023
Personalized Dietary Regimens for Inflammatory Bowel Disease: Current Knowledge and Future Perspectives
Wellens J, Vissers E, Matthys C, Vermeire S, Sabino J
Pharmacogenomics and Personalized Medicine 2023, 16:15-27
Published Date: 12 January 2023
High Expression of DNTTIP1 Predicts Poor Prognosis in Clear Cell Renal Cell Carcinoma
Wang X, Li W, Lou N, Han W, Hai B, Xiao W, Zhang X
Pharmacogenomics and Personalized Medicine 2023, 16:1-14
Published Date: 6 January 2023